Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

Gustafson, who is now 72 and lives in Delray Beach, Florida, went to the emergency room for fluids, thinking she was dehydrated. In a surreal moment, the Australian doctors instead told Gustafson that she had pancreatic cancer.

“They were very adamant about it,” Gustafson said. “This is absolutely pancreatic cancer.”